Jiacheng Liu

14PUBLICATIONS
19CO-AUTHORS
HaematologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Gastroenterology and hepatologyMedical devices
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jan 28, 2026
Efficacy and Safety of HAIC Combined with PD-(L)1 Inhibitors and Bevacizumab Versus HAIC with PD-(L)1 Inhibitors and TKIs in Advanced Hepatocellular Carcinoma: A Retrospective Cohort Study.

Zizhuo Wang, Wei Xu, Songlin Song

|Jan 25, 2025
Peptides as Versatile Regulators in Cancer Immunotherapy: Recent Advances, Challenges, and Future Prospects.

Yu Lei, Jiacheng Liu, Yaowei Bai

|Jan 10, 2024
Synergistic Effects of Nanoscale CaO2 Combined with PD-1 Inhibitors in the Treatment of Hepatocellular Carcinoma: A Promising Combination.

Yingliang Wang, Shuguang Ju, Huimin Zhou

|Aug 26, 2023
Reversion of liver cirrhosis after endovascular treatment in Chinese patients with Budd-Chiari syndrome.

Chaoyang Wang, Tongqiang Li, Kequan Chen

|May 13, 2022
Shape Designed Implanted Drug Delivery System for In Situ Hepatocellular Carcinoma Therapy.

Chaochao Zhao, Qin Shi, Hu Li

|Mar 15, 2022
Sarcopenia in Patients with Cirrhosis after Transjugular Intrahepatic Portosystemic Shunt Placement.

Jiacheng Liu, Jinqiang Ma, Chongtu Yang

Pageof 3

Frequent Collaborators

10 joint publications

Bin Xiong

3 joint publications

Chongtu Yang

3 joint publications

Songjiang Huang

2 joint publications

Yaowei Bai